Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
26.26
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Novavax’s dispute resolution and upcoming earnings call
February 23, 2024
Novavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer.
Via
MarketBeat
Topics
Earnings
Exposures
COVID-19
Financial
Recession-Proof Riches: 7 Stocks to Buy for Bulletproof Portfolio Growth
February 23, 2024
Explore recession-proof stocks thriving in Energy, Health Care, Industrials, and more, offering stability and growth amid economic turmoil.
Via
InvestorPlace
3 No-Brainer Stocks to Buy Right Now for Less than $50
February 23, 2024
You won't have to shell out much cash to invest in these great stocks.
Via
The Motley Fool
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
Pfizer Inc (NYSE: PFE) is among the many pharmaceutical companies that turned to oncology in response to sinking demand for its COVID-19 products and near patent expiration dates for its several...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Better Bull Market Buy: Novavax vs. Pfizer
February 22, 2024
Bull markets usually favor stocks with promising growth prospects.
Via
The Motley Fool
Pfizer Unusual Options Activity For February 21
February 21, 2024
Via
Benzinga
Exploring NYSE:PFE's dividend characteristics.
February 20, 2024
Exploring PFIZER INC (NYSE:PFE)'s dividend characteristics.
Via
Chartmill
7 Stocks to Buy for Bargain Hunters on the Prowl
February 22, 2024
Wager on these top bargain stocks poised for a comeback, offering both long-term gains and income, away from the growth stock bubble.
Via
InvestorPlace
Why Range-Bound Moderna Could Get A Boost On Its Fourth-Quarter Report
February 22, 2024
The company unexpectedly came in with fourth-quarter earnings that beat projections.
Via
Investor's Business Daily
Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus
February 21, 2024
Moderna reports Q4 earnings on Feb. 22. Analysts expect $2.53B in revenue. Stock has faced challenges but potential for recovery with COVID-19 vaccine and FDA approval in 2024.
Via
Benzinga
Exposures
COVID-19
Product Safety
These 3 Dividend Stocks Yield More Than 5% but Their Payout Ratios Are Over 100%. Are Dividend Cuts Coming?
February 21, 2024
Relying on payout ratio alone can sometimes give investors a misleading picture of just how safe a dividend payment is.
Via
The Motley Fool
3 Cheap Dividend Stocks to Snatch Up Now
February 20, 2024
Cheap dividend stocks offer rebound upside paired with an income source that is difficult to beat for most investors.
Via
InvestorPlace
Get Rich Quick with These 7 Growth Stocks to Buy Now
February 20, 2024
Here are seven growth stocks to buy that will let you know by their price action if the current bull market is ready to expand.
Via
InvestorPlace
Wall Street Favorites: 7 Long-Term Stocks With Strong Buy Ratings for February 2024
February 20, 2024
The stock market is soaring, and many analysts are worried about a bubble. Still, these seven long-term stocks are still great buys today.
Via
InvestorPlace
2 Ultra-High-Yield Dividend Stocks Billionaires Can't Stop Buying, and 1 They Can't Sell Fast Enough
February 20, 2024
Two brand-name income stocks with yields north of 6% were gobbled up by prominent billionaires in the December-ended quarter, while a dividend stock with a 15% yield found itself on the chopping...
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 19, 2024
Via
Benzinga
European Commission Approves Pfizer’s VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis
February 19, 2024
From
Pfizer Inc.
Via
Business Wire
7 Blue-Chip Stocks to Pick Up While They’re Down
February 18, 2024
Build a robust investment portfolio and make the most of the discount with these blue-chip stocks to buy and hold.
Via
InvestorPlace
ROSEN, A TOP RANKED LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
February 18, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
ROSEN, A TOP RANKED LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
February 18, 2024
WHY: NEW YORK, NY - (NewMediaWire) - February 18, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
February 17, 2024
Patience will be rewarded with these stocks.
Via
The Motley Fool
MarketBeat Week in Review – 2/12 - 2/16
February 17, 2024
Higher inflation readings dampened expectations for rate cuts, and a shortened trading week may get more volatile when many retail stocks report earnings
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Pfizer's Expansion Sparks Boom for these Healthcare REITs
February 16, 2024
Via
Benzinga
7 F-Rated Stocks to Sell for February 2024
February 16, 2024
The stock market is off to a good start and there are plenty of great names out there. So don't hold on to your F-rated stocks to sell.
Via
InvestorPlace
Pfizer's Mixed Bag: A Look At The Fourth Quarter 2023 Earnings Call - Main Takeaways
February 15, 2024
Pfizer Inc. (NYSE: PFE) recently held its fourth-quarter earnings call, revealing a year of contrasts for the pharmaceutical giant. While the company faced setbacks, particularly with its COVID-19...
Via
Benzinga
Topics
Earnings
Exposures
COVID-19
Financial
The 3 Biotech Stocks That Could Make Your February Unforgettable
February 15, 2024
After a blistering hot year of biotech M&A, we’ll see more of the same in 2024. That could be great news for these hot biotech stocks.
Via
InvestorPlace
Pfizer Invites Public to Register for Webcast of Pfizer Oncology Innovation Day
February 15, 2024
From
Pfizer Inc.
Via
Business Wire
The 7 Best Dividend Stocks to Buy in February 2024
February 15, 2024
The market is soaring and many sectors appear overvalued. Fortunately, these leading dividend stocks are still available at great prices.
Via
InvestorPlace
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024
EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NYSE:MRK) EQNX::TICKER_END
Via
FinancialNewsMedia
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024
From
FN Media Group LLC
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.